These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 38871078)
21. Metabolic modelling of the human gut microbiome in type 2 diabetes patients in response to metformin treatment. Ezzamouri B; Rosario D; Bidkhori G; Lee S; Uhlen M; Shoaie S NPJ Syst Biol Appl; 2023 Jan; 9(1):2. PubMed ID: 36681701 [TBL] [Abstract][Full Text] [Related]
22. The role of gut microbiota in obesity, diabetes mellitus, and effect of metformin: new insights into old diseases. Pascale A; Marchesi N; Govoni S; Coppola A; Gazzaruso C Curr Opin Pharmacol; 2019 Dec; 49():1-5. PubMed ID: 31015106 [TBL] [Abstract][Full Text] [Related]
23. Akkermansia muciniphila, which is enriched in the gut microbiota by metformin, improves cognitive function in aged mice by reducing the proinflammatory cytokine interleukin-6. Zhu X; Shen J; Feng S; Huang C; Wang H; Huo F; Liu H Microbiome; 2023 May; 11(1):120. PubMed ID: 37254162 [TBL] [Abstract][Full Text] [Related]
24. Metformin and Dipeptidyl Peptidase-4 Inhibitor Differentially Modulate the Intestinal Microbiota and Plasma Metabolome of Metabolically Dysfunctional Mice. Ryan PM; Patterson E; Carafa I; Mandal R; Wishart DS; Dinan TG; Cryan JF; Tuohy KM; Stanton C; Ross RP Can J Diabetes; 2020 Mar; 44(2):146-155.e2. PubMed ID: 31445961 [TBL] [Abstract][Full Text] [Related]
25. Changes and Significance of Central Carbon Metabolism before and after Metformin Treatment of Type 2 Diabetes Based on Mass Spectrometry. Shu Y; Yang F; Li W; Li L; Hu Q; Xiong D Discov Med; 2024 Apr; 36(183):678-689. PubMed ID: 38665017 [TBL] [Abstract][Full Text] [Related]
26. The gut microbiome and type 2 diabetes status in the Multiethnic Cohort. Maskarinec G; Raquinio P; Kristal BS; Setiawan VW; Wilkens LR; Franke AA; Lim U; Le Marchand L; Randolph TW; Lampe JW; Hullar MAJ PLoS One; 2021; 16(6):e0250855. PubMed ID: 34161346 [TBL] [Abstract][Full Text] [Related]
27. Gut Microbiota and Blood Metabolites Related to Fiber Intake and Type 2 Diabetes. Wang Z; Peters BA; Yu B; Grove ML; Wang T; Xue X; Thyagarajan B; Daviglus ML; Boerwinkle E; Hu G; Mossavar-Rahmani Y; Isasi CR; Knight R; Burk RD; Kaplan RC; Qi Q Circ Res; 2024 Mar; 134(7):842-854. PubMed ID: 38547246 [TBL] [Abstract][Full Text] [Related]
28. Comprehensive relationships between gut microbiome and faecal metabolome in individuals with type 2 diabetes and its complications. Zhao L; Lou H; Peng Y; Chen S; Zhang Y; Li X Endocrine; 2019 Dec; 66(3):526-537. PubMed ID: 31591683 [TBL] [Abstract][Full Text] [Related]
30. Metformin, Cognitive Function, and Changes in the Gut Microbiome. Rosell-Díaz M; Fernández-Real JM Endocr Rev; 2024 Mar; 45(2):210-226. PubMed ID: 37603460 [TBL] [Abstract][Full Text] [Related]
31. Metformin Strongly Affects Gut Microbiome Composition in High-Fat Diet-Induced Type 2 Diabetes Mouse Model of Both Sexes. Silamiķele L; Silamiķelis I; Ustinova M; Kalniņa Z; Elbere I; Petrovska R; Kalniņa I; Kloviņš J Front Endocrinol (Lausanne); 2021; 12():626359. PubMed ID: 33815284 [TBL] [Abstract][Full Text] [Related]
32. Effects of Non-insulin Anti-hyperglycemic Agents on Gut Microbiota: A Systematic Review on Human and Animal Studies. Cao TTB; Wu KC; Hsu JL; Chang CS; Chou C; Lin CY; Liao YM; Lin PC; Yang LY; Lin HW Front Endocrinol (Lausanne); 2020; 11():573891. PubMed ID: 33071980 [No Abstract] [Full Text] [Related]
33. Metformin Reduces Blood Glucose in Treatment-Naive Type 2 Diabetes by Altering the Gut Microbiome. He D; Han H; Fu X; Liu A; Zhan Y; Qiu H; Ma L; Zhang X; Wang X Can J Diabetes; 2022 Mar; 46(2):150-156. PubMed ID: 35148952 [TBL] [Abstract][Full Text] [Related]
34. Gut Microbiome Profiles Are Associated With Type 2 Diabetes in Urban Africans. Doumatey AP; Adeyemo A; Zhou J; Lei L; Adebamowo SN; Adebamowo C; Rotimi CN Front Cell Infect Microbiol; 2020; 10():63. PubMed ID: 32158702 [TBL] [Abstract][Full Text] [Related]
35. Effects of 12-week treatment with dapagliflozin and gliclazide on faecal microbiome: Results of a double-blind randomized trial in patients with type 2 diabetes. van Bommel EJM; Herrema H; Davids M; Kramer MHH; Nieuwdorp M; van Raalte DH Diabetes Metab; 2020 Apr; 46(2):164-168. PubMed ID: 31816432 [TBL] [Abstract][Full Text] [Related]
36. Metformin increases gut multidrug resistance genes in type 2 diabetes, potentially linked to Escherichia coli. Kim HB; Cho YJ; Choi SS Sci Rep; 2024 Sep; 14(1):21480. PubMed ID: 39277620 [TBL] [Abstract][Full Text] [Related]
37. Effects of combination treatment with metformin and berberine on hypoglycemic activity and gut microbiota modulation in db/db mice. Lyu Y; Li D; Yuan X; Li Z; Zhang J; Ming X; Shaw PC; Zhang C; Kong APS; Zuo Z Phytomedicine; 2022 Jul; 101():154099. PubMed ID: 35489323 [TBL] [Abstract][Full Text] [Related]
38. Effect of metformin and metformin/linagliptin on gut microbiota in patients with prediabetes. Martínez-López YE; Neri-Rosario D; Esquivel-Hernández DA; Padron-Manrique C; Vázquez-Jiménez A; Sánchez-Castañeda JP; Girón-Villalobos D; Mendoza-Ortíz C; Reyes-Escogido ML; Evia-Viscarra ML; Aguilar-Garcia A; Resendis-Antonio O; Guardado-Mendoza R Sci Rep; 2024 Apr; 14(1):9678. PubMed ID: 38678119 [TBL] [Abstract][Full Text] [Related]
39. Effect of metformin on metabolic improvement and gut microbiota. Lee H; Ko G Appl Environ Microbiol; 2014 Oct; 80(19):5935-43. PubMed ID: 25038099 [TBL] [Abstract][Full Text] [Related]
40. Considering gut microbiota in treatment of type 2 diabetes mellitus. Adeshirlarijaney A; Gewirtz AT Gut Microbes; 2020 May; 11(3):253-264. PubMed ID: 32005089 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]